Clinical Trial Update: 5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence [NA]

View source ↗

Summary

A completed clinical trial investigating 5HT3 antagonists for treating opioid withdrawal and preventing progression of physical dependence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence
• Opioid Withdrawal

Snippet

Sponsor: Stanford University | Conditions: Opioid Withdrawal, Physical Dependence | NA | Status: COMPLETED | Results posted: 2019-01-07